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The physiological responses to TGF-b stimulation are diverse and vary amongst different cell types
and environmental conditions. Even though the principal molecular components of the canonical
and the non-canonical TGF-b signaling pathways have been largely identiﬁed, the mechanism that
underlies the well-established context dependent physiological responses remains a mystery.
Understanding how the components of TGF-b signaling function as a system and how this system
functions in the context of the global cellular regulatory network requires a more quantitative
and systematic approach. Here, we review the recent progress in understanding TGF-b biology using
integration of mathematical modeling and quantitative experimental analysis. These studies reveal
many interesting dynamics of TGF-b signaling and how cells quantitatively decode variable doses of
TGF-b stimulation.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. The basics of transforming growth factor-b signaling
TGF-b is the prototypical ligand of the TGF-b superfamily, which
signal through receptor serine/threonine kinases. The superfamily
is subdivided into two branches: (1) the TGF-b/Activin branch
and (2) the Bone Morphogenetic Protein (BMP)/Growth and Differ-
entiation Factor (GDF) branch. Each branch is further divided into
subgroups based on sequence similarity [1]. The TGF-b/Activin
branch includes TGF-b, Activin, Inhibin, Nodal, and Lefty ligands.
The BMP/GDF branch includes BMP, GDF, and Mullerian Inhibitory
Substance (MIS) ligands. This review will focus on the quantitative
analyses of TGF-b signaling, which is the most studied ligand in
terms of basic signal transduction mechanisms. There are also sub-
stantial quantitative studies of BMP signaling, especially in the
context of morphogen gradient formation and interpretation,
which have been covered in several excellent reviews [2–5].
TGF-b is expressed in most cell types and is translated into a
proprotein that is proteolytically cleaved into a non-covalently
linked mature TGF-b and latency-associated protein (LAP) [6,7].
The active TGF-b ligand is a 25 kDa dimer, covalently linked by a
disulﬁde bond between cysteine residues from each monomericchemical Societies. Published by E
ctor-b; TbRI, TGF-b type I
Morphogenetic Protein; GDF,
ferential equations; P-Smad2,
).peptide. When bound to LAP, TGF-b cannot bind to its receptors,
resulting in a ligand that lacks bioavailability. Its bioavailability
is further restricted by binding to another protein called Latent
TGF-b Binding Protein (LTBP). The LAP–TGF-b complex is bound
by LTBP during the secretion process [6]. LTBP binds the extracel-
lular matrix and sequesters LAP–TGF-b in vivo [6]. Various prote-
ases cleave LAP and LTBP to liberate the bioactive TGF-b [8].
Bioactive TGF-b can bind various non-receptor cell surface proteins
such as decorin, biglycan, and betaglycan, which also serve to reg-
ulate its bioavailability, most likely through the enrichment of
TGF-b at the plasma membrane [6,7]. Therefore, multiple mecha-
nisms serve to regulate the bioavailability of TGF-b in vivo.
Once bioavailable TGF-b reaches the surface of the target cell, it
binds a homodimer of TGF-b type II receptors (TbRII) [1]. The TGF-
b–TbRII complex provides a structural interface that facilitates sta-
ble complex formation with a homodimer of the TGF-b type I
receptor (TbRI) [8]. Therefore, the active ligand–receptor complex
is a heterotetrameric complex consisting of a dimer of TGF-b and
homodimers of both TbRII and TbRI. Within the active receptor
complex, the TbRII, which is a constitutively active kinase, under-
goes autophosphorylation, as well as catalyzes transphosphoryla-
tion of the TbRI [8]. Transphosphorylation of the TbRI activates
kinase activity. In the TGF-b pathway, Smad2 and Smad3 are recep-
tor-regulated effector proteins (R-Smads), which are phosphory-
lated by the activated TbRI at a C-terminal SSXS motif, resulting
in R-Smad nuclear accumulation [8].
TGF-b signaling amplitude and duration can be regulated
through the control of receptor trafﬁcking. The ligand boundlsevier B.V. All rights reserved.
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Internalization of cell surface receptors can occur through either
clathrin-mediated or caveolae-mediated endocytosis [10]. Through
the clathrin pathway, activated ligand–receptor complexes are
brought into early endosomes which are enriched with scaffold
proteins such as SARA and Hrs [9]. The proximity of the activated
receptor complex and scaffold proteins enhances the phosphoryla-
tion of Smad2/3 and their afﬁnity towards Smad4, ultimately
activating the nuclear accumulation of Smad4 (also known as the
co-Smad) [11]. Therefore, clathrin-mediated endocytosis may
promote TGF-b signaling by providing a platform for R-Smad phos-
phorylation and the formation of active Smad signaling complexes.
Ligand–bound receptor complexes in the early endosomes are fur-
ther sorted to late endosomes, where TGF-b and the receptors are
separated. Some of the unbound receptors can be recycled to the
plasma membrane, while others are degraded, along with TGF-b,
upon fusion with the lysosomes [10]. Since TGF-b is not recycled,
internalization of TGF-b by endocytosis is the primary means of
removing active TGF-b from the cell surface, and lysosomal degra-
dation is the primary means of termination of TGF-b signaling
[12,13].
Activation of TGF-b receptors initiates both Smad-dependent
and Smad-independent signaling events [14–16]. Since the major-
ity of the quantitative studies of TGF-b signaling have focused on
Smad-dependent events, we will focus our discussion on the
dynamics of the canonical pathway (Smad-dependent). In unstim-
ulated cells, Smads constitutively shuttle between the cytoplasm
and nucleus. Upon ligand stimulation, the Smads accumulate in
the nucleus as the R-Smad/Co-Smad complex formation, which
leads to a decrease in their nuclear export rate [17–19]. The Smad
complex binds DNA in conjunction with other transcription factors
and interacts with the general transcription machinery to regulate
the expression of approximately 100–300 target genes [11]. Phos-
phatase(s) such as PPM1A can deactivate phospho-R-Smads,
resulting in the disassembly of the Smad complex and providing
a means for negative regulation of TGF-b signaling in the nucleus
[18]. Therefore, the intracellular Smad signaling module is a
dynamic circuit for ligand sensing.
2. Mathematical modeling of the TGF-b signaling pathway
Conventional cell signaling studies have largely focused on
understanding the identity and the functions of the individual
parts of each pathway. It is now realized that cell behaviors are
not only shaped by the identity of the individual system compo-
nents, but also by the weighted interactions of components that
act together as a system. The systems biology approach using
mathematical models has been proven as a powerful tool in study-
ing such complex networks [20]. Mathematical modeling is helpful
in predicting emergent cell behaviors and uncovering how the dy-
namic interactions of signal transducers lead to context dependent
cellular responses [21]. Several mathematical models have been
established for the canonical TGF-b/Smad signaling [13,17,22–
29]. These mathematical models provide quantitative analyses of
TGF-b signaling dynamics, leading to a better understanding of
the role of feedbacks in regulating TGF-b signaling responses.
The most common way to describe TGF-b signaling dynamics is
through a set of deterministic ordinary differential equations
(ODEs), assuming the signaling molecules are well-mixed or
homogenous in each compartment [20]. The ODEs represent the
change of each signaling molecule over time. In order to perform
model simulations and predictions, it is necessary to know the val-
ues for two types of model parameters: the initial conditions of the
pathway that correspond to the concentrations of the signaling
molecules at time 0 (before TGF-b stimulation) and the rate con-stants that characterizes the signaling reactions. The principal
molecular components of TGF-b signaling have been identiﬁed,
yet relatively little is known about the quantitative values of par-
ticular components’ abundance and rate constants. The lack of
experimental data on initial conditions and rate constants is cur-
rently one of the bottlenecks for developing high-quality predictive
mathematical models for signaling networks.
Different approaches have been applied to estimate the model
parameters. The initial conditions of the signaling network can
be determined by the absolute abundance of the signaling proteins
and the volume of the signaling compartment. It is possible to esti-
mate the absolute abundance of a signaling protein when the re-
combinant protein is available. For example, the absolute
abundance of Smad2 protein per cell can be quantiﬁed by immu-
noblotting with a standard curve of recombinant tagged-Smad2
protein [30]. Cell volume is sometimes roughly estimated from cell
diameter or it can be measured more accurately by confocal
microscopy [31]. On the other hand, direct measurement of the
rate constants for different signaling reactions is still experimen-
tally challenging. In order to estimate the unknown model param-
eters, optimization algorithms are applied to ﬁnd the most feasible
parameters that make model simulations ﬁt the experimental
datasets as close as possible [32,33]. During the past few years,
some quantitative data has been experimentally measured for
the TGF-b signaling pathway, aiding the modeling efforts for this
network [10,13,19,25]. Fig. 1 summarizes our current knowledge
about the model parameters for the canonical TGF-b/Smad signal-
ing network.
3. Quantitative analysis of signaling responses to different TGF-
b stimulations
The cellular responses to TGF-b superfamily ligands depend on
the quantity to which the cells are exposed. In development, TGF-b
superfamily members form morphogen gradients to determine the
fates of cells [2]. Cells read the TGF-b concentration with high pre-
cision, as they can distinguish subtle differences in the concentra-
tion gradients and orchestrate different cell fates [34]. One of the
best examples is the responses of embryonic Xenopus cells to acti-
vin, in which ﬁve distinct cell responses or fates are observed by
varying activin doses [34]. However, the mechanism by which cells
are able to accurately decode the concentration of bioavailable
TGF-b and elicit a corresponding cellular response remains largely
unknown.
3.1. The Smad signaling response correlates with TGF-b molecules per
cell rather than the concentration of TGF-b
An early study with mathematical models has shown that cell
density affects signaling dynamics in response to the same concen-
tration of ligand [35]. Through modeling analyses of receptor traf-
ﬁcking networks, Zi et al. showed that with the same concentration
of ligand stimulation, cells have distinct signaling durations that
depend upon cell density, where signaling persists longer when
cell density is decreased [35]. Additionally, the model analyses
indicate that the dose–response curve of signaling is shifted to
the right as the cell density is increased, suggesting that increasing
cell density allows for insensitivity to lower doses of ligand. Thus,
the key parameter for successful experimental design cannot be
‘‘concentration of ligand’’, but rather must be ‘‘molecules of ligand
per cell’’, which takes into account the number of cells in the
experiment. Further model simulations indicate that signaling re-
sponses are regulated by the ratio of ligand to cell surface receptor
number [35]. In cell culture experiments, individual cells are likely
to express different amounts of receptors at cell surface. Thus,
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Fig. 1. Scheme of the compartmentalized TGF-bmodel. The kinetic parameter information is approximately estimated according to the experimental data from different cell
types. The nuclear export rate constants of Smads are scaled with the ratio of cytoplasmic to nuclear volume size. It is necessary to calibrate these parameter values with
quantitative data sets for modeling of TGF-b signaling responses in a speciﬁc cell type.
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of ligand to cell surface receptor number in each cell will be differ-
ent, which might cause heterogeneous signaling responses at sin-
gle cell level.
To provide additional evidence that cellular responses to ligand
occur in terms of ‘‘molecules per cell’’ rather than by the concen-
tration of the ligand, Clarke et al. investigated how cells transduce
TGF-b doses into variable kinetic proﬁles of Smad2 phosphoryla-
tion at C-terminal SSXS motif (P-Smad2) by quantitative experi-
mental assays [12]. Clarke et al. measured P-Smad2 levels in a
two-level factorial experiment by varying four experimental
parameters (TGF-b concentration, cell number at seeding, plate
type, and medium volume). When the P-Smad2 data is plotted ver-
sus TGF-b concentration, large variations are observed for the same
TGF-b concentration among different experimental setups. In con-
trast, the variation of P-Smad2 levels is signiﬁcantly reduced if
these levels are plotted versus the number of TGF-b molecules
per cell. This result implies that the ligand dose expressed as
TGF-b molecules per cell is a better predictor of P-Smad2 levels,
which is in agreement with early modeling studies about the im-
pact of cell density on signaling response.
Ligand depletion in the TGF-b network provides additional com-
plexity and increases the difﬁculty of predicting the time depen-
dent signaling responses. For example, the number of TGF-b
molecules per cell in the media changes substantially with time
because the cells deplete TGF-b from the surrounding medium. It
was shown that TbRII defective, but not TbRI defective, cell lines
lost their ability to deplete TGF-b from the medium [12]. Thus,
TbRII helps to shape the Smad signal amplitude and duration by
constitutively depleting extracellular TGF-b. TGF-b depletion mostlikely occurs through TbRII-mediated endocytosis. However, direct
evidence that supports this notion remains to be presented in the
literature. In this aspect, TGF-b degradation shares many similari-
ties to EGF or TGF-a [36,37] in that ligand-induced endocytosis
does not merely serve as a mechanism for ‘‘down-regulation’’ of
signaling, but also provides a mechanism whereby the receptor
can continuously track the changes in the secretion of TGF-b by
nearby cells. It should be noted that most studies of TGF-b signal-
ing assume that TGF-b concentration in the medium is sufﬁcient to
describe the input variable (potency of ligand). Consequently, most
modeling studies have assumed a constant level of TGF-b during
signaling over time. However, in cell based experiments TGF-b con-
centration in the medium changes substantially with time, espe-
cially for low doses of TGF-b. Therefore, the assumption that
TGF-b concentration is constant in medium might be appropriate
for high doses of TGF-b, but it is invalid for low doses of TGF-b.
3.2. TGF-b dose–responses are time dependent
Earlier experimental and modeling analyses showed that Smad
signal amplitude is gradually increased with the increments of
TGF-b doses [23,24,38]. This leads to an important question about
how cells convert continuous TGF-b doses into discrete or binary
cellular fate decisions. Since most of modeling studies in the
TGF-b ﬁeld do not account for the TGF-b input variable by assum-
ing constant TGF-b concentration in medium, this omission often
results in unreliable predictions of Smad signaling kinetics in re-
sponse to variable doses of TGF-b stimulation [13]. Recently, we
developed an improved mathematical model to describe the
dynamics of Smad signaling in response to TGF-b [13]. The model
1924 Z. Zi et al. / FEBS Letters 586 (2012) 1921–1928was composed of TGF-b receptor trafﬁcking, Smad phosphorylation
and Smad nucleocytoplasmic shuttling. More importantly, it took
into account the dynamics of TGF-b depletion. Model parameters
were estimated by ﬁtting to several time course datasets, which in-
clude variables of TGF-b depletion in the medium, Smad2 nuclear
localization and P-Smad2 dynamics. The model was further tested
for its ability to predict the P-Smad2 signaling upon pulsation of
TGF-b stimulations. With this data-calibrated model, novel predic-
tions were made through model simulations. It was shown that
TGF-b signaling responses display different sensitivities to ligand
doses at different time scales [13]. In this study, modeling simula-
tions and experimental results show that while short-term P-
Smad2 is graded, long-term P-Smad2 response is switch-like to
changes in TGF-b doses (Fig. 2). In the short-term graded response,
P-Smad2 signal gradually increases with the increment of TGF-b
dose. In the long-term switch-like response, a small change of
TGF-b dose within a certain range results in a large change in
P-Smad2 response. Furthermore, a switch-like response is ob-
served for TGF-b induced long-term gene expression and growth
inhibitory responses. Additional model perturbation experiments
predicted that the long-term switch-like P-Smad2 response is
mainly affected by the parameters related to the ligand depletion.
This prediction was experimentally conﬁrmed [13].
3.3. The TGF-b pathway is insensitive to high frequency noise
While extensive studies have focused on signaling responses to
continuous TGF-b stimulations, little is known about how cells re-
spond to short pulses of TGF-b stimulations. Taking advantage of
model simulations, Zi et al. have shown that short-term TGF-b
pulse stimulation results in transient P-Smad2, whereas serial
pulses result in sustained P-Smad2, similar to that seen with con-
tinuous stimulation [13]. To generate a sustained response, the gap# TGF-β molecules/c
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Fig. 2. Model simulations for the time-course proﬁle of P-Smad2 dose–response in HaCaT
early P-Smad2 signal (e.g. before 2 h) displays a graded response to different doses of T
ultrasensitive signaling response is critical for cellular fate decisions, for example, cell gbetween repeated pulse stimulation is 30 min. This result sug-
gests that with a strong TGF-b stimulation, the pre-bound recep-
tors are capable of sustaining the signaling response for half of
an hour and tiding it to the next stimulus. Incidentally, this optimal
gap period is approximately the time to reach maximum Smad2
phosphorylation and nuclear accumulation of Smad2 after TGF-b
stimulation [13]. Therefore, there is a time-delay in the TGF-b sig-
naling system, which may be attributed to ligand-bound receptor
endocytosis or Smad nucleocytoplasmic shuttling dynamics. Be-
cause of this built-in time-delay, the TGF-b signaling system can
ﬁlter high frequency changes (short time pulsations) in ligand
stimulations. Thus, combining mathematical modeling with
guided experiments enables new discoveries in systems properties
of TGF-b signaling that would have been difﬁcult to reveal using
the traditional biochemical approaches alone. The functional sig-
niﬁcance of pulses of TGF-b has yet to be shown in vivo, but is the-
oretically occurring within tissues, where the extracellular volume
and local secretion of TGF-b is extremely small in magnitude,
resulting in a largely noisy extracellular level of TGF-b. Such noise
would then be dampened by the delayed TGF-b response that has
been observed in cell culture models.
4. Quantitative analysis of transient and sustained signaling
responses
The duration of signaling responses can be critical for alerting
cell fate decisions in response to growth factor. Previous work with
PC12 cells showed that epidermal growth factor (EGF) induces
transient activation of extracellular signal-regulated kinase (ERK)
and results in cell proliferation, while sustained ERK activation
triggered by nerve growth factor (NGF) leads to cell differentiation
[39,40]. Although some of these effects could be due to non-ERK
dependent responses to the different ligands, these experimentsell
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lation can determine the prevailing cellular response.
In the case of the TGF-b signaling network, the duration of Smad
signaling response seems to be context dependent. Experimental
studies have shown that keratinocyte epithelial cells have sus-
tained phospho-Smad responses to TGF-b, while some ﬁbroblast
and tumor cells display transient Smad activation [41,42]. It was
hypothesized that sustained TGF-b signaling may be required for
growth inhibition, while transient signaling may cause the resis-
tance to anti-proliferative effects of TGF-b in certain tumor cells
[41]. However, the exact mechanism underlying the variation of
Smad signal duration in different cell types remains to be
elucidated. Here we summarize the time dependent changes in
the cellular responses to TGF-b.
4.1. Sequestration of TGF-b receptors by endocytosis
TGF-b signaling is initiated by the binding of TGF-b to TbRI and
TbRII. The activation of the ligand–receptor complex is a relatively
fast step in the TGF-b signal transduction pathway. An early study
from Wrana et al. shows that the phosphorylation of TbRI in the
receptor complex peaks at about 2 min after TGF-b stimulation
[43]. The signal is relayed to the activation of Smad proteins, which
arrive at their maximal levels in about 30–60 min. The time delay
between ligand–receptor complex and R-Smad activation may due
to intermediate processes, including receptor endocytosis, the
recruitment of Smads to receptor complex and Smad activation.
After 30–60 min, the phosphorylation of Smads correlates with
the degree of TGF-b–receptor complex level, which might be due
continuous nucleocytoplasmic shuttling of the Smads, but this
shuttling fails to explain why there is a prominent delay following
receptor activation and prior to Smad phosphorylation [25,44].
Although it has been shown that two main types of endocytosis
mediate the internalization of TGF-b receptors, clathrin-dependent
and clathrin-independent [9,45], different lines of experimental
evidence display discrepancies in the requirement of receptor
internalization for Smad phosphorylation. Using potassium deple-
tion, which interferes with clathrin-dependent internalization of
receptors, P-Smad2 levels are reduced in Mv1Lu cells [10,46]. On
the other hand, potassium depletion or mutant dynamin (K44A)
in L17-TbRI cells reveals that receptor trafﬁcking is entirely dis-
pensable for TGF-b signaling to occur [9,47]. Even though there is
little debate about whether the TGF-b receptors undergo endocyto-
sis, the precise role of receptor endocytosis in signaling remains
controversial [9]. Several lines of evidence support a positive role
of endocytosis on R-Smad phosphorylation [10,46,48,49], while
there are several reports describing Smad activation immediately
at the cell surface without need of receptor endocytosis
[47,50,51]. The disagreement among these studies could be attrib-
uted to different cell types and experimental systems. Despite the
variable effects of receptor endocytosis on Smad phosphorylation,
activation of non-Smad signaling pathways by TGF-b appears to re-
quire receptor internalization [51,52].
To understand the role of receptor endocytosis on TGF-b signal-
ing, mathematical models were established by focusing on TGF-b
receptor endocytosis. Vilar et al. developed a concise model for
TGF-b receptor trafﬁcking and the ligand–receptor interactions.
This model predicts that the duration of signaling activity is deter-
mined by the ratio of the constitutive to the ligand-induced degra-
dation rate of the receptors, termed the ‘‘constitutive-to-induced
degradation ratio’’ (CIR). Model analyses suggest that signal activ-
ity is transient with a low CIR, while sustained signal response is
observed with a high CIR. The model has some assumptions includ-
ing: (1) TGF-b signaling activity is proportional to the level of li-
gand–receptor complexes in the internalized endosomes, and (2)
Ligand–receptor complexes between type I and type II receptorshave the same constitutive degradation rate. In addition, the model
lumps the processes including non-clathrin dependent internaliza-
tion, recycling and the degradation of the receptors into one reac-
tion as ‘‘the ligand-induced receptor degradation from plasma
membrane’’. Thus, CIR deﬁned in Vilar’s model is not directly
determined by the ratio of the reaction rate constants for constitu-
tive and ligand-induced degradations. Instead, it refers to the bal-
ance of the overall effect of the combined processes of the two
branches of receptor degradation machinery.
Subsequently, a mathematical model developed by Zi and Klipp
includes twomajor types of TGF-b receptor endocytosis, Smad acti-
vation and Smad nuclearcytolasmic shuttling [29]. Similar as
Vilar’s model, the extended model assumes that Smad activation
is proportional to the ligand–receptor complex in early endosomes.
The model simulations using different sets of parameter values
suggest that Smad activation is regulated by the balance between
clathrin dependent endocytosis (kiEE) and caveolar/lipid-raft
mediated (clathrin-independent) endocytosis (kiCave). If clathrin-
dependent internalization is dominant (kiEE >> kiCave), Smad
activation becomes a sustained response. On the other hand, if
clathrin-independent endocytosis is overwhelming (kiCave >> kiEE),
Smad activation displays a transient response. Interestingly, the
simulation results suggest that changing the balance between the
two branches of endocytosis has relatively little effect on the early
Smad signal, and has larger effect in reshaping long term Smad
activity. This hypothesis might explain the variations among
experimental observations about the impact of inhibiting TGF-b
receptor endocytosis on TGF-b signaling responses, where the dif-
ferent model systems may have different ratio of clathrin-depen-
dent to clathrin-independent endocytosis. Thus, in a cell line
with similar rates of clathrin-dependent and clathrin-independent
endocytosis, an inhibition of clathrin-dependent will make clath-
rin-independent endocytosis (ligand–induced receptor degrada-
tion) dominant and result in a reduction in Smad activity. In
other cell types, if the clathrin-dependent endocytosis is over-
whelmed by clathrin-independent endocytosis, inhibiting clath-
rin-dependent internalization will not shift the balance between
these two endocytosis branches and should result in little effect
on the perturbation of signaling responses. Moreover, the inhibi-
tors of endocytosis used in previous experimental studies may
not be very speciﬁc and could have some off target effects. In the
future, a systems biology approach can be useful to clarify this is-
sue by combining mathematical models with quantitative experi-
mental data of receptors and Smad kinetics.
4.2. Quantitative analysis of the dynamics of Smad nuclear import and
export
A prominent feature of TGF-b signaling is the continuous shut-
tling of Smads in and out the nucleus, in both treated and
untreated cells [44,53]. Ligand-induced nuclear accumulation of
R-Smad and Co-Smad is relatively slow and peaks at 45 min after
TGF-b exposure. Ligand-induced Smad shuttling dynamics is con-
sidered to be a prevailing mechanism for Smads to continuously
monitor receptor activity [44,53]. Different mechanisms have been
invoked to account for Smad nucleocytoplasmic shuttling dynam-
ics. Mathematical modeling analysis has been instrumental in dif-
ferentiating various hypotheses [18]. Clarke et al. [17] was the ﬁrst
to publish a kinetic model of Smad signaling dynamics. The simple
kinetic model includes R-Smad phosphorylation/dephosphoryl-
aton, heterodimerization with Smad4, and nucleocytoplasmic
shuttling steps. Analyzing the existing data with this model led
to several novel hypotheses for Smad nuclear accumulation during
TGF-b signaling. Through parameter sensitivity analysis, Clarke
et al. posited that (1) the balance between the rates of R-Smad
phosphorylation in the cytoplasm and phospho-R-Smad dephos-
1926 Z. Zi et al. / FEBS Letters 586 (2012) 1921–1928phorylation in the nucleus determines Smad nuclear accumulation.
(2) Smad homo- or hetero-oligomerization could protect the phos-
pho-R-Smads from rapid dephosphorylation and therefore pro-
mote Smad nuclear accumulation. (3) Nuclear retention factors
alone are insufﬁcient for induction of Smad nuclear accumulation.
Schmierer et al. investigated the relationship between receptor
activation and Smad shuttling dynamics using a combined mathe-
matical modeling and systematic experiment approach [25]. Two
competing models were developed based on different assumptions
of the Smad import mechanism. The retention/enhanced complex
import (RECI) model assumes Smad complexes to be imported at
a faster rate than the monomeric species, while the retention only
(RO) model sets identical import rates for both Smad complexes
and monomeric species but only allows nuclear retention of com-
plexes. The two competing models were simultaneously ﬁt to four
sets of kinetic empirical data. The result of comparative analysis
shows that RECl is clearly a more accurate model. Moreover, the
RECl model also shows excellent agreement with ﬂuorescence
recovery after photobleaching (FRAP) data of GFP-Smad2 that were
not used to construct the model. The FRAP experiment was used to
infer the shuttling of GFP-Smad2 between nucleus and cytoplasmic
compartments. Therefore, quantitative analysis of Smad shuttling
led to the notion that the Smad complex must have a faster nuclear
import rate and that the phosphatase(s) that deactivate R-Smads
likely resides in the nucleus. A novel insight that comes out of
the modeling analysis is that time-delayed coupling between
receptor activity and Smad nuclear accumulation could function
as a low-pass ﬁlter to dampen the noise in receptor activity
[25,54].
4.3. Negative feedbacks in TGF-b signaling
Negative feedback in a signal transduction cascade is one of the
major mechanisms for desensitization of sustained ligand stimula-
tion and generation of transient, sometimes oscillating signaling
outputs [55]. Even though transient or oscillatory responses asso-
ciated with sustained TGF-b exposure are not ubiquitous, potential
negative feedback motifs have been identiﬁed. The most well char-
acterized example is Smad7, a TGF-b-inducible early response gene
[56,57]. Smad7 antagonizes TGF-b signaling through multiple
mechanisms, both in the cytosol and the nucleus. Since Smad7
can bind the TGF-b receptors, but lacks the SXSS motif commonly
found in R-Smads, it has been proposed that Smad7 is likely to
be a pseudo substrate and a competitive inhibitor of R-Smads
[56,57]. Owing to its ability to form stable complexes with the
TGF-b receptors, PP1 phosphatase [58], or the ubiquitination E3
ligase Smurf1 and Smurf2 [59], Smad7 serves as an adapter to
mediate inactivation of TGF-b receptors through dephosphoryla-
tion or ubiquitin-proteasomal degradation. Besides targeting
receptors for inactivation, Smad7 also appears to be involved in
repressing TGF-b-dependent transcription through either the dis-
ruption of R-Smad/Co-Smad/DNA complexes or the recruitment
of histone deacetylases [60]. Regardless of the exact biochemical
mechanisms of Smad7, the induction of Smad7 by TGF-b and its
function as an antagonist for TGF-b signaling are very compelling.
A key question is, ‘‘what is the strength of this feedback and to
what degree does it impact TGF-b signal transduction.’’ Melke et
al. analyzed a more comprehensive model of TGF-b/Smad signaling
in endothelial cells that included canonical Smad signaling. They
found that negative feedback through Smad7 was important for
terminating signaling and for conferring global robustness to the
TGF-b pathway [24].
TMEPAI is another antagonist of TGF-b signaling and is trans-
criptionally induced by ligand exposure [61]. TMEPAI possesses
both transmembrane and Smad interacting domain (SIM). The
inhibition of TGF-b signaling can be attributed to sequestrationof both unphosphorylation and phosphorylated R-Smads from
interacting with the receptors or Smad4 [61]. While inhibition of
TGF-b signaling by Smad7 and TMEPAI predominantly occurs in
the early step of signaling propagation, the negative feedback loop
that involves SnoN appears to target the downstream signaling
cascade at the chromatin level. SnoN and its relative Ski are both
transcriptional co-repressors of the Smad signaling complex
[62,63]. In the early phase of TGF-b stimulation, SnoN is destabi-
lized by association with activated R-Smads and ubiquitin E3 li-
gases such as Arkadia [64–67]. Degradation of SnoN/Ski
unleashes the full activity of the Smad complex, resulting in the
transcriptional activation of target genes. SnoN is one of the TGF-
b inducible genes and the elevated SnoN restrains the activity of
Smad complexes [64]. Therefore, there are at least three negative
feedback loops associated with TGF-b signaling. All of these are ini-
tiated by transcriptional induction of the antagonist, although spa-
tial and temporal variations exist among them.
4.4. Are there oscillations in TGF-b signaling responses?
Oscillations of signaling responses have been observed in some
pathways with negative feedbacks, for example, NF-jB, p53 and
Erk systems [37,68,69]. Modeling analyses have shown that bio-
chemical oscillations can occur if four general requirements are
satisﬁed: negative feedback, time delay, non-linearity of the reac-
tion kinetics, and tightly controlled timescales of opposing chemi-
cal reactions [70]. Since different negative feedbacks have been
proposed for regulating TGF-b signaling [71], theoretically, it is
possible to generate oscillating responses in the TGF-b network.
Recent modeling analyses by extensive sampling of parameter
space show that oscillating Smad signaling can appear by ﬁne-tun-
ing only a few parameters related to negative feedback (e.g.
Smad7) [22,28]. However, it is still an open question about
whether there are oscillations in TGF-b network because no oscil-
lations of TGF-b signaling have yet been observed in cells. One rea-
son could be that the negative feedback regulations of TGF-b
network may not be strong enough at the endogenous level. More-
over, the time-delay between negative feedback and Smad activa-
tion might not be coupled in a proper time scale at in vivo
conditions. Last but not least, cell signaling often results in hetero-
geneous responses within single cells. Averaging signaling dynam-
ics at cell population levels can mask dynamic signaling
mechanisms within individual cells [72]. Oscillation responses
may appear upon investigation at the single cell level in a variety
of cell lines and culture conditions.
4.5. Modeling cell context speciﬁc TGF-b signaling
It has been long recognized that the cellular responses triggered
by TGF-b are often cell type speciﬁc and stimulation speciﬁc [73].
For example, TGF-b is a potent inhibitor of normal epithelial cell
proliferation but acts to stimulate ﬁbroblast growth [73]. Even in
the same cell type, TGF-b can produce opposite proliferation effects
depending on the presence of other growth factors. In the presence
of PDGF, TGF-b stimulates growth of Myc-1 cells, and in the pres-
ence of EGF, TGF-b inhibits growth of the exact same cells [73]. The
exact molecular mechanisms underlying these contradictory cellu-
lar responses remain largely elusive. One possible explanation to
account for these observations is that the pathways activated by
TGF-b vary among different cell types and are restrained by cross-
talk with other signaling pathways. Even though TGF-b signals
through Smad2 and Smad3 in most cell types through ALK-5, in
endothelial and hepatic stellate cells TGF-b induces phosphoryla-
tion of both Smad1/5 and Smad2 via ALK-1 and ALK-5, respectively
[24,38,74]. Based on this evidence, Melke et al. developed a math-
ematical model for the TGF-b pathway in endothelial cells, taking
Z. Zi et al. / FEBS Letters 586 (2012) 1921–1928 1927parallel activation of ALK1 and ALK5 into consideration. Their mod-
el recapitulates the kinetics of the experimental data and correctly
predicts the behavior in experiments where the system is per-
turbed [24]. This study highlights a need to develop mathematical
modeling tailored to a speciﬁc biological context in order to under-
stand the multifunctional nature of TGF-b signaling.
5. Outlook and concluding remarks
TGF-b signaling is spatiotemporally regulated in at least three
compartments (extracellular, cytosol and nucleus). Quantitative
analysis of the TGF-b signaling pathway is still very much in its in-
fancy. At present, modeling efforts have been focused on the
canonical TGF-b signaling cascade. As TGF-b signals through both
canonical and non-canonical pathways, it is imperative to develop
mathematical models that comprise both pathways in order to
accurately predict overall TGF-b signaling. Since the non-canonical
pathway is often cell type dependent and operates in the context of
other signaling networks, it will be a major challenge to develop
such models. Another challenge is to understand the quantitative
coupling between Smad signaling kinetics and gene expression
proﬁles. Most of the mathematical models developed so far assume
that the dynamics of Smad2 and Smad3 phosphorylation is similar
and indistinguishable. However, the biological functions of Smad2
and Smad3 are clearly different, based on mouse knockout studies
and DNAmicroarray analysis [75,76]. The abundance of Smad2 and
Smad3 varies signiﬁcantly in different cell types and the ratio of
Smad2 and Smad3 inﬂuences the resulting cellular responses to
TGF-b stimulation [17,77]. Future modeling efforts need to
consider how to model the R-Smads separately. Finally, given the
emerging role of TGF-b type III receptor in modulating TGF-b sig-
naling [78], it would be interesting to quantitatively assess their
contributions to the signaling dynamics. As more quantitative
TGF-b signaling data becomes readily accessible, we anticipate that
the innovative systems biology approach to study TGF-b/Smad sig-
naling will fundamentally advance our knowledge in this major
signaling network.
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